atrazine has been researched along with B16 Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karrow, NA | 1 |
| McCay, JA | 1 |
| Brown, RD | 1 |
| Musgrove, DL | 1 |
| Guo, TL | 1 |
| Germolec, DR | 1 |
| White, KL | 1 |
1 other study available for atrazine and B16 Melanoma
| Article | Year |
|---|---|
Oral exposure to atrazine modulates cell-mediated immune function and decreases host resistance to the B16F10 tumor model in female B6C3F1 mice.
Topics: Administration, Oral; Animals; Atrazine; Crosses, Genetic; Dose-Response Relationship, Drug; Female; | 2005 |